Bellerophon Therapeutics, Inc. Debt Instrument, Fee Amount
Bellerophon Therapeutics, Inc. had Debt Instrument, Fee Amount of $300.00 thousand as of 2019-12-16, per its 10-K filed 2021-03-11.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentFeeAmount · last filed 2021-03-11
- 2019-12-16: Debt Instrument, Fee Amount $300.00K.
| Period end | Debt Instrument, Fee Amount |
|---|---|
| 2019-12-16 | $300.00K 10-K · filed 2021-03-11 |